蒋永容, 陈川, 张志敏, 郑继军, 许文, 罗美林, 戴楠, 李梦侠. miRNA-122a靶基因预测及生物信息学分析[J]. 中国肿瘤临床, 2011, 38(16): 931-934. DOI: 10.3969/j.issn.1000-8179.2011.16.001
引用本文: 蒋永容, 陈川, 张志敏, 郑继军, 许文, 罗美林, 戴楠, 李梦侠. miRNA-122a靶基因预测及生物信息学分析[J]. 中国肿瘤临床, 2011, 38(16): 931-934. DOI: 10.3969/j.issn.1000-8179.2011.16.001
Yongrong JIANG, Chuan CHEN, Zhimin ZHANG, Jijun ZHENG, Wen XU, Meilin LUO, Nan DAI, Mengxia LI. Bioinformatic Analysis and Prediction of miRNA-122a Target Genes[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(16): 931-934. DOI: 10.3969/j.issn.1000-8179.2011.16.001
Citation: Yongrong JIANG, Chuan CHEN, Zhimin ZHANG, Jijun ZHENG, Wen XU, Meilin LUO, Nan DAI, Mengxia LI. Bioinformatic Analysis and Prediction of miRNA-122a Target Genes[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 38(16): 931-934. DOI: 10.3969/j.issn.1000-8179.2011.16.001

miRNA-122a靶基因预测及生物信息学分析

Bioinformatic Analysis and Prediction of miRNA-122a Target Genes

  • 摘要: 利用基因芯片技术分析肝癌HepG2细胞和正常肝上皮LO2细胞中miRNA的表达,并对HepG2细胞中低表达的miRNA-122a进行靶基因预测及相关生物信息学分析,为以miRNA-122a为靶点的基因治疗提供理论和实验基础。方法:利用基因芯片技术检测HepG2细胞和LO2细胞中miRNA-122a表达水平,通过生物信息学预测miRNA-122a的靶基因,并对其靶基因进行功能富集分析(GO-analysis)、信号转导通路富集分析(Pathway-analysis)和蛋白质相互作用网络分析。结果:与LO2细胞比较,miRNA-122a在HepG2细胞中呈低表达。miRNA-122a预测靶基因有1 104个,其靶基因集合功能分别富集于碳水化合物生物合成、核苷酸代谢、细胞因子受体结合、细胞周期等生物学过程(P<0.001);信号转导通路显著富集于JAK-STAT信号通路、Wnt信号通路、MAPK信号通路、ErbB信号通路、细胞周期等信号转导通路(P<0.001)。结论:miRNA-122a在HepG2细胞中呈现低表达,miRNA-122a预测靶基因集合显著富集在与肿瘤发生相关的信号通路中。

     

    Abstract: The present study aimed to investigate miRNA expression patterns in hepatocellular carcinoma ( HepG2 ) and normol liver epithelial (LO2) cell lines. Another aim was to bioinformatically analyze as well as predict the target genes of miR-122a to provide both theoretical and experimental basis for gene therapy. Methods: The expression levels of miRNA-122a in HepG2 and LO2 cells were detected using the gene chip technology. The bioinformatic analysis of the target genes of miRNA-122a involved enrichment ( gene ontology ), signal transduction pathway enrichment, and protein interaction network analyses. Results: miRNA-122a expression significantly decreased in HepG2 cells, compared with LO2 cells. The number of miRNA-122a target genes was 1104. The functions of these target genes were enriched in carbohydrate biosynthesis, nucleotide metabolism, cytokine receptor binding, cell cycle, and other biological processes ( P < 0.001 ). The JAK-STAT signaling, Wnt signaling, MAPK signaling, ErbB signaling, and cell cycle signal transduction pathways were significantly enriched ( P < 0.001 ). Conclusion: miRNA-122a expression significantly decreased in HepG2 cells. Some of the predicted target genes of miRNA-122a were significantly enriched in tumor related with signaling pathways.

     

/

返回文章
返回